Hilde Langseth, MSc PhD

Researcher, Head of Unit, Biobank-based Research Unit - Janus Serum Bank

Research interests:
Cancer epidemiology
Biobank - and register based research

Cancer types:
Lung cancer
Ovary and other gynecological cancers
Gastrointestinal cancers
Prostate cancer

Research areas:
Etiological research
Early detection biomarkers of cancer
miRNA and cancer  
Occupational and environmental exposures and cancer


Janus Serum Bank 
JanusRNA - identification of early cancer biomarkers 
Forskning på miljøgifter og kreft
Kreftrisiko blant landbruksarbeidere

Selected international collaborations

  1. Imperial College London, School of Public Health, Department of Epidemiology and Biostatistics, UK
  2. National Cancer Institute, Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology & Genetics, USA
  3. International Agency for Research of Cancer, Lyon, France
  4. DKFZ – German Cancer Research Center, Heidelberg, Germany

Selected publications:

Umu SU, Langseth H, Keller A, Meese E, Helland Å, Lyle R,Rounge TB (2019) "A 10 year prediagnostic followup study shows that serum RNA signals are highly dynamic in lung carcinogenesis" Mol Oncol Epub 2019/12/19

Chen D, Grimsrud TK, Langseth H, et al. (2020) "Prediagnostic serum concentrations of organochlorine pesticides and non-Hodgkin lymphoma: A nested case–control study in the Norwegian Janus Serum Bank Cohort."Environmental Research 2020;187:109515.

Irvin S, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, Wentzensen N (2020) "Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank" Cancer Epidemiol Biomarkers rev, 29 (3), 636-642

Rounge TB, Umu SU, Keller A, Meese E, Ursin G, Tretli S, Lyle R, Langseth H (2018)
"Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity" Sci Rep, 8 (1), 17650

Keller A, Rounge T,  Backes C, Ludwig N,  Gislefoss R, Leidinger P, Langseth H, Meese E. (2017) "Sources to variability in circulating human miRNA signatures". RNA Biol.Vol 14(12), 1791-1798

Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth, H (2017) "Cohort Profile Update: The Janus Serum Bank Cohort in Norway". International Journal of Epidemiology, 2017, 1–8. Advance Access published January 12, 2017.

 Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G. (2016) "Cohort Profile: The Janus Serum Bank Cohort in Norway." Int J Epidemiol. 2016. Epub. Apr 10. 



Updated September 28 2020

Regarding questions received by the Cancer Registry of Norway

The Cancer Registry of Norway is a research institute. Our staff will therefore not answer questions on diagnosis and treatment or on follow-up from individual patients or their families. These questions should be directed to your physician, hospital or the Cancer Helpline of the Norwegian Cancer Society, Telephone: 800-57 338 (800 KREFT)

Back to Researchers at the Cancer registry of Norway